Skip to main content
. 2011 Apr 6;96(6):1633–1641. doi: 10.1210/jc.2011-0168

Table 2.

Diagnoses in 2598 patients who underwent at least one pituitary MRI from January 1999 to November 2010

Diagnoses Total Number of masses, [age range], and (average age), at initial pituitary MRIa
Newly diagnosedb Pathologyc
Males Females
Anterior pituitary tumors
    Prolactinoma 395 90 [17–81] (46) 305 [15–89] (36) 182 54
    Nonfunctioning adenoma 364 162 [18–85] (54) 202 [17–87] (47) 166 164
    GH adenoma 127 59 [19–84] (49) 68 [18–82] (45) 31 43
    ACTH adenoma 84 18 [19–77] (43) 66 [10–66] (38) 47 34
    GH/prolactin mixed adenoma 4 3 [24–42] (32) 1 [15] 1 4
    Nelson's syndrome 2 0 [24–42] (30) 2 [44–66] (50) 1 0
    Pituitary carcinomad 2 2 [45–75] (60) 0 2 2
    LH/FSH functioning adenoma 1 1 [59] 0 0 1
    TSH adenoma 1 0 1 [31] 1 1
    GH/TSH mixed adenoma 1 0 1 [35] 1 0
Cysts
    Rathke's cleft cyst 42 12 [14–75] (40) 30 [2–68] (40) 35 25
    Craniopharyngioma 33 13 [1–54] (29) 20 [8–73] (45) 12 20
    Arachnoid 2 2 [33–56] (45) 0 0 1
    Epidermoid 1 0 1 [67] 1 1
    Pineal cyst 1 1 [11] 0 1 0
Nonadenomatous neoplasms
    Meningioma 32 7 [28–81] (52) 25 [33–89] (64) 15 13
    Chordoma 3 3 [24–69] (43) 0 1 3
    Pituitary lymphoma 2 1 [48] 1 [81] 2 2
    Chondrosarcoma 1 0 1 [24] 1 1
    Embryonal rhabdomyosarcoma 1 0 1 [10] 0 1
    Germinoma 1 1 [12] 0 1 1
    Granular cell tumor 1 0 1 [53] 0 1
    Hemangiopericytoma, malignant 1 0 1 [77] 1 1
    Leiomyosarcoma 1 0 1 [36] 1 1
    Mucoepidermoid carcinoma 1 0 1 [40] 0 1
    Pituicytoma 1 1 [38] 0 0 1
    Xanthogranuloma 1 1 [25] 0 1 1
Inflammatory and vasculitidies
    Lymphocytic hypophysitis 3 1 [45] 2 [26–34] (30) 1 2
    Hypophysitis, unspecified type 2 0 2 [37–54] (46) 0 0
    Lymphocytic infundibulitis 1 0 1 [29] 0 1
    Amyloidosis, primary 1 0 1 [54] 1 0
    Sarcoidosis 1 1 [37] 0 0 0
    Wegener's granulomatosis 1 1 [44] 0 1 1e
Infectious
    Pseudomonas aeruginosa 1 1 [40] 0 1 1
    Syphilis 1 1 [38] 0 1 0
Metastases
    Breast 3 0 3 [32–69] (52) 3 1
    CNS lymphoma, to pituitary stalk 1 1 0 [72] 1 1
    Nasopharyngeal lymphoma 1 0 1 [44] 1 1
    Liver epitheliod hemangioendothelioma 1 1 [51] 0 0 1
    Lung, adenocarcinoma 1 1 [71] 0 1 0
    Pineal germinoma/dysgerminoma 1 1 [18] 0 1 1
    Plasmacytoma 1 1 [60] 0 1 1
    Prostate, adenocarcinoma 1 1 [59] 0 1 1
    Sinusoidal squamous cell carcinoma 1 0 1 [70] 1 1
Vascular
    Apoplexy with masses 16 9 [37–70] (54) 7 [23–88] (50) 13 9
    Carotid aneurysm 4 2 [57–78] (68) 2 [41–86] (64) 4 n/a
    Hypothalamic cavernous angioma 1 0 1 [38] 1 0
    Hypothalamic interpeduncular hematoma 1 1 [31] 0 1 1
Miscellaneous
    Empty sella 21 5 [18–48] (36) 16 [32–62] (47) 16 n/a
    Hyperplasia 14 0 14 [14–58] (40) 10 11
    Ectopic pituitary gland 4 2 [14 days–25] (12) 2 [17–67] (42) 4 0
    Fibrous dysplasia 3 0 3 [26–67] (47) 1 2
    Lipoma 1 0 1 [23] 1 0
Hypothalamic
    Astrocytoma 2 0 2 [13–37] (25) 1 1
    Germinoma 1 1 [26] 0 0 0
    Hamartoma 1 0 1 [10] 0 0
Undiagnosed masses 159 48 [15–93] (48) 111 [10–89] (43) n/a 5f
Normal pituitary 1242 436 [2 months–88] (44) 806 [2–91] (39) n/a 21

n/a, Not applicable.

a

Age specified in years, unless otherwise noted. Age range and average noted if applicable;

b

masses diagnosed after initial pituitary MRI; includes undiagnosed incidentalomas;

c

number of pathological reports available at this institution to confirm diagnoses;

d

two cases of pituitary carcinomas initially diagnosed as prolactinomas, which changed at time of biopsy after initial pituitary MRI;

e

pathology confirmed by serological tests;

f

five patients with nondiagnostic pathology results.